Document Detail


DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes.
MedLine Citation:
PMID:  11431104     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objectives of this study were to examine DNA demethylase (dMTase) expression in ovarian cancers and evaluate methylation of CpG sites in the promoter of the c-erbB-2 gene and survivin gene exon 1. Forty-three epithelial ovarian cancers and 43 non-cancerous ovarian tissues were studied for dMTase expression by RT-PCR. Genomic DNA was extracted and digested with HindIII and then HpaII. CpG site-sensitive primers were constructed to amplify the promoter of the c-erbB-2 gene and survivin gene exon 1. Immunohistochemical evaluation of ErbB-2 protein and RT-PCR for survivin were also performed. dMTase was positive in 88.4% of ovarian cancers but only in 9.3% of non-cancerous ovaries (P<0.001, Fisher's exact test). The expression was similarly observed in both early stage (stage I+II: 17/19) and advanced stage (stage III+IV: 21/24) groups of ovarian malignancy. It was found that 78.9% of dMTase-positive cancers had both c-erbB-2 promoter and survivin gene exon 1 unmethylated, whereas 40% of dMTase-negative cancers had both sites methylated. In non-cancerous ovaries, these sites were mostly methylated (90.6%) and the difference from cancer cases was highly significant (P<0.001). Immunohistochemical evaluation of ErbB-2 showed significant correlation of unmethylated c-erbB-2 promoter and ErbB-2 expression. The RT-PCR for survivin expression showed that 86% of cancers were positive and six cases were negative. Exon 1 was methylated in 83% of the survivin-negative cases. This is the first report of dMTase expression in ovarian cancers. The correlation of dMTase expression with unmethylation of c-erbB-2 promoter and survivin gene exon 1 suggests that these sites may be targets for demethylation by the enzyme. The up-regulation of oncogenes may be the consequence of epigenetic control of gene expression by the dMTase.
Authors:
M Hattori; H Sakamoto; K Satoh; T Yamamoto
Related Documents :
19043454 - In vitro and in vivo analysis of b-myb in basal-like breast cancer.
17522714 - Nuclear microenvironments in biological control and cancer.
17298854 - Diagnostic relevance of overexpressed mrna of novel oncogene with kinase-domain (nok) i...
10514394 - Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immun...
23980144 - Ether lipid generating enzyme agps alters the balance of structural and signaling lipid...
15288254 - Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer letters     Volume:  169     ISSN:  0304-3835     ISO Abbreviation:  Cancer Lett.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-06-29     Completed Date:  2001-08-16     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  155-64     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Nihon University School of Medicine, 30-1, Oyaguchi, Kamimachi, Itabashi, 173-0861, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
CpG Islands*
DNA / metabolism
DNA Methylation*
DNA, Complementary / metabolism
Exons
Female
Humans
Immunohistochemistry
Microtubule-Associated Proteins*
Middle Aged
Neoplasm Proteins
Ovarian Neoplasms / genetics,  metabolism*
Ovary / pathology
Oxidoreductases, O-Demethylating / biosynthesis*
Polymerase Chain Reaction
Promoter Regions, Genetic*
Proteins / genetics*
Receptor, erbB-2 / genetics*
Reverse Transcriptase Polymerase Chain Reaction
Temperature
Chemical
Reg. No./Substance:
0/BIRC5 protein, human; 0/DNA, Complementary; 0/Microtubule-Associated Proteins; 0/Neoplasm Proteins; 0/Proteins; 9007-49-2/DNA; EC 1.-/Oxidoreductases, O-Demethylating; EC 1.-/methyl-CpG DNA demethylase; EC 2.7.10.1/Receptor, erbB-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Post-initiation treatment of Indole-3-carbinol did not suppress N-methyl-N-nitrosourea induced mamma...
Next Document:  Cancer procoagulant and blood platelet activation.